Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.05
Delayed Data
As of 10:46am ET
 +0.01 / +0.49%
Today’s Change
1.99
Today|||52-Week Range
7.85
-35.39%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.04
Today’s open2.09
Day’s range2.02 - 2.10
Volume37,716
Average volume (3 months)52,244
Market cap$5.6M
Dividend yield--
Data as of 10:46am ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.14

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-0.01-0.67%
CYANCyanotech Corp+0.14+3.49%
BVXVBiondVax Pharmaceuti...-0.02-0.33%
ISRIsoRay Inc+0.01+0.98%
Data as of 10:59am ET, 02/27/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts


Search for Jobs